Skip to main content
Equibles

NORTHERN TRUST CORP

Bank

Position in LRMR — Larimar Therapeutics, Inc.

CIK 73124 CHICAGO, IL
Back to LRMR Full portfolio

Position in LRMR

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,678,309
-$15,954 QoQ
Shares Held
550,266
+46.2% QoQ
Ownership
0.530%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#24
of 163 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 98% Shared 2% None 0%

Common Shares in LRMR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

NORTHERN TRUST CORP holds $7,872,952,300 across 424 Biotechnology names. LRMR ranks #239 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,486,478 $1,235,108,212
2 REGN
Regeneron Pharmaceuticals, Inc.
 916,467 $571,453,829
3 ALNY
Alnylam Pharmaceuticals, Inc.
 886,900 $266,983,504
4 RPRX
Royalty Pharma plc
 4,718,859 $264,586,419
5 RVMD
Revolution Medicines, Inc.
 1,117,110 $209,212,357
6 MRNA
Moderna, Inc.
 2,985,329 $209,062,587
7 INCY
Incyte Corp
 1,761,966 $199,736,460
8 CYTK
Cytokinetics Inc
 1,647,345 $140,337,319

All Filings in LRMR

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,678,309 550,266
2026-03-31 $1,694,263 376,503
2025-12-31 $1,359,311 356,775
2025-09-30 $1,221,930 378,307
2025-06-30 $994,103 343,981
2025-03-31 $786,185 365,668
2024-12-31 $1,456,890 376,458
2024-09-30 $2,269,796 346,534
2024-06-30 $2,166,959 298,891
2024-03-31 $2,242,252 295,422
2023-12-31 $1,220,727 268,292
2023-09-30 $935,190 236,757
2023-06-30 $654,488 209,102
2023-03-31 $228,896 50,529
2022-12-31 $207,573 50,260
2022-09-30 $68,256 21,330
2022-06-30 $41,806 21,330
2022-03-31 $86,386 21,330
2021-12-31 $230,150 21,330
2021-09-30 $270,931 23,498
2021-06-30 $239,195 24,358
2021-03-31 $355,870 24,358
2020-12-31 $525,337 24,537
2020-09-30 $283,132 18,664